Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) P/E ratio
As of 5 November 2026, Integer Holdings Corporation (ITGR) trades at a P/E ratio of 42.2×. Over the past ten years it has ranged from 0.0× (December 2016) to 216× (March 2017); the current reading is higher than 84% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 26.9× | (27.84%) |
| FY2024 | 37.2× | 3.07% |
| FY2023 | 36.1× | 5.50% |
| FY2022 | 34.2× | 17.20% |
| FY2021 | 29.2× | (15.45%) |
| FY2020 | 34.5× | 27.15% |
| FY2019 | 27.2× | 85.28% |
| FY2018 | 14.7× | (32.16%) |
| FY2017 | 21.6× | (86.10%) |
| FY2016 | 156× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 42.1× | 66.29% |
| Jun 2026 | 25.3× | 16.84% |
| Mar 2026 | 21.7× | (19.30%) |
| Dec 2025 | 26.9× | (35.02%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NEOG Neogen Corporation compare | n/m |
| AXGN AxoGen, Inc. compare | n/m |
| IRTC iRhythm Holdings, Inc. compare | n/m |
| TXG 10x Genomics compare | n/m |
| TMDX TransMedics Group, Inc. compare | 16.4× |
| LIVN LivaNova PLC compare | 25.6× |
| UFPT UFP Technologies, Inc. compare | 30.1× |
| ITGR Integer Holdings Corporation | 42.2× |
| HAE Haemonetics Corporation compare | 54.5× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement